Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
280
NCT04224857
SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 1, 2019
Completion: Apr 30, 2020
NCT04583358
Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)
Phase: Phase 2
Start: Aug 26, 2020
Completion: Dec 31, 2022
NCT04741087
Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis
Start: Feb 5, 2021
Completion: Apr 22, 2022
NCT05372939
Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)
Completion: Jul 13, 2022
NCT05476107
SAD Study to Assess the Safety, Tolerability, PK, and In-Vivo Performance of AMT-126 in Healthy Male and Female Subjects
Start: Feb 26, 2021
Completion: Mar 26, 2022